Patent details

Basic Information

Publication number:

EP3673911

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP201540499

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY

French Title of Invention:

COMPOSITIONS ET MÉTHODE POUR L'IMMUNOTHÉRAPIE DU CANCER

German Title of Invention:

ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE KREBSIMMUNTHERAPIE

SPC Number:

Dates

Filing date:

18/08/2017

Grant date:

20/03/2024

EP Publication Date:

01/07/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/03/2024

EP B1 Publication Date:

20/03/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/08/2024

Expiration date:

18/08/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/03/2024

 

 

Name:

IN8bio, Inc.

Address:

Empire State Building 350 Fifth Avenue, Suite 5330, New York, NY 10118, United States (US)

Name:

The UAB Research Foundation

Address:

710 13th Street South CSB 120, Birmingham, AL 35233, United States (US)

Inventor

1

Name:

LAMB, Lawrence S.

Address:

United States (US)

2

Name:

HO, William

Address:

United States (US)

Priority

Priority Number:

201662376680 P

Priority Date:

18/08/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 35/17; C12N 5/0783; A61K 31/495; A61K 39/395;

Publication

European Patent Bulletin

Issue number:

202412

Publication date:

20/03/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages